NASDAQ:FLGT

Fulgent Genetics Earning Date

USA |NASDAQ |USD

FLGT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $3.25 $2.47 $2.08
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $264.00M $153.62M $101.72M

Fulgent Genetics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

FLGT Earnings Date & History Chart

FLGT Earnings & Revenue Forecast

FLGT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $1.89 $1.89 $1.89
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $14.24 $14.24 $14.24
Dec 2022 1 $5.60 $5.60 $5.60

FLGT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $1.59 $1.40 $1.45
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $12.25 $12.32 $12.45
Dec 2022 1 / 0 $3.82 $3.26 $3.36

FLGT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $171.20M $171.20M $171.20M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $948.20M $948.20M $948.20M
Dec 2022 1 $534.80M $534.80M $534.80M

FLGT Earnings Date & Revenue History

FLGT Earnings History

|
Show More
Show More

FLGT Revenue History

|
Show More
Show More

Fulgent Genetics Next Earnings Date & Report

FLGT Next Earnings Date & Report Preview: Sep 2021 (FQ)

FLGT's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 1 analysts, the average EPS estimation for Fulgent Genetics's next quarterly earnings is $3.25, with a low EPS estimation of $3.25, and a high estimation of $3.25.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $1.29, the last 2 month trend is $1.61, and the 3 month trend is $1.72.

Based on 3 analysts, the average revenue estimation is $264.00M, with a low revenue estimation of $264.00M, and a high estimation of $264.00M.

Fulgent Genetics Previous Earnings Dates & Reports

FLGT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Fulgent Genetics's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.

FLGT's earnings per share (EPS) was $2.47, missing the consensus analysts forecast of $2.67 by -7.58%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -62.15%, and higher than the same period a year before (Jun 2020) by 1351.59%.

Revenues were $153.62M, better than the forecast of $153.62M by 0.00%, down by -57.26% from the previous quarter , and up by 789.75% from the same period last year.

The company reported a net income of $79.81M, -60.23% lower than the previous quarter, and higher by 2303.25% than the same period a year before.

Free cash flow for the quarter was $73.18M , compared to $221.69M last quarter and $-4.82M a year before.

FLGT ended the quarter with $21.98M in total debt, an increase of 46.05% compared to the previous quarter, and an increase of 667.35% compared to the same quarter a year before.

FLGT Previous Earnings Date & Report Recap: Dec 2020 (FY)

Fulgent Genetics's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.

FLGT's earnings per share (EPS) was $8.42, beating the consensus analysts forecast of $6.28 by 34.08% , and higher than the previous year's EPS (Dec 2019) by 4577.78%.

Revenues were $421.71M, better than the forecast of $326.20M by 29.28%, and up by 1196.46% from previous year's revenue.

The company reported a net income of $214.31M.

Fulgent Genetics reported a free cash flow of $104.12M for its fiscal year, compared to $4.20M a year ago.

The company ended the fiscal year with $15.85M in total debt, an increase of 492.45% compared to the previous year.